Publications by authors named "M C Klotz"

Article Synopsis
  • Cementless fixation is becoming more important in total knee arthroplasty (TKA), and this article reviews its functional outcomes and how long the implants last.
  • A thorough literature search identified 15 studies published between 2010 and 2022, with 11 comparing cementless to cemented TKA and 4 focusing solely on cementless implants.
  • The findings suggest that cementless TKA has functional outcomes and survivorship that are at least as good as cemented implants, and advancements in technology may lead to increased adoption of cementless methods in the future.
View Article and Find Full Text PDF

The search for long-lived quantum memories, which can be efficiently interfaced with flying qubits, is longstanding. One possible solution is to use the electron spin of a color center in diamond to mediate interaction between a long-lived nuclear spin and a photon. Realizing this in a nanodiamond furthermore facilitates the integration into photonic devices and enables the realization of hybrid quantum systems with access to quantum memories.

View Article and Find Full Text PDF

As our planet grapples with the severe repercussions of plastic pollution, mechanical recycling has been proposed as a potential remedy. However, increasing mechanical recycling may have unintended negative consequences. For example, recycling of PVC flooring containing hazardous plasticizers that were used in the past may lead to continued exposure.

View Article and Find Full Text PDF

Background: In recent years, the indication for cementless short stem total hip arthroplasty (THA) has been widened to elderly patients as they might profit by the advantages of the short-curved implant design as well. Therefore, this study was conducted to evaluate the clinical and radiological outcome of a cementless short stem in elderly patients (≥ 75 years) compared to a young control group (≤ 60 years).

Methods: A retrospective cohort of 316 THAs performed between 2014 and 2017 was prospectively examined.

View Article and Find Full Text PDF

Purpose: Initially, prostate cancer responds to hormone therapy, but eventually resistance develops. Beta emitter-based prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy is approved for the treatment of metastatic castration-resistant prostate cancer. Here we introduce a targeted alpha therapy (TAT) consisting of the PSMA antibody pelgifatamab covalently linked to a macropa chelator and labeled with actinium-225 and compare its efficacy and tolerability with other TATs.

View Article and Find Full Text PDF